# Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults

> **NCT00537147** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 26 (actual)

## Conditions studied

- West Nile Fever

## Interventions

- **BIOLOGICAL:** WN/DEN4delta30 vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00537147
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00537147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00537147, "Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00537147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*